For the quarter ending 2026-03-31, BRNS has $92,143K in assets. $25,665K in debts. $65,858K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 65,858 | 70,456 | 74,272 | 86,259 |
| Assets held for sale | - | - | 138 | 413 |
| Restricted cash | 1,331 | 1,396 | 1,402 | 1,525 |
| Research and development incentives receivable | 1,232 | 1,108 | 4,633 | 4,536 |
| Prepaid expenses and other current assets | 4,243 | 4,830 | 6,336 | 7,681 |
| Total current assets | 72,664 | 77,790 | 86,781 | 100,414 |
| Property and equipment, net | 3,270 | 3,523 | 4,519 | 4,514 |
| Intangible assets, net | 13,666 | 14,288 | 14,909 | 20,366 |
| Right of use assets, net | 1,629 | 1,638 | 2,063 | 3,323 |
| Other assets | 914 | 930 | 929 | 944 |
| Total assets | 92,143 | 98,169 | 109,201 | 129,561 |
| Accounts payable | 993 | 350 | 698 | 1,800 |
| Accrued expenses and other current liabilities | 8,685 | 6,249 | 6,681 | 7,364 |
| Deferred income | 318 | 1,396 | 1,402 | 1,525 |
| Operating lease liability - current | 2,005 | 2,023 | 2,017 | 2,036 |
| Total current liabilities | 12,001 | 10,018 | 10,798 | 12,725 |
| Operating lease liability - non-current | 9,003 | 9,258 | 9,553 | 9,952 |
| Contingent consideration | 2,956 | 2,871 | 2,508 | 2,544 |
| Other non-current liabilities | 1,468 | 1,476 | 1,461 | 1,468 |
| Deferred tax liability, net | 237 | 254 | 320 | 391 |
| Total liabilities | 25,665 | 23,877 | 24,640 | 27,080 |
| Ordinary shares, 0.000025 nominal value 40,848,893 shares authorized, issued and outstanding (december31, 2025 authorized, issued and outstanding 40,848,893) | 1 | 1 | 1 | 1 |
| Deferred a shares, 1 nominal value 63,443 shares authorized, issued and outstanding (december31, 2024 authorized, issued and outstanding 63,443)-Deferred Shares. | - | - | 86 | 86 |
| Deferred a shares, 1 nominal value 63,443 shares authorized, issued and outstanding (december31, 2025 authorized, issued and outstanding 63,443) | 86 | 86 | - | - |
| Additional paid-in capital | 394,499 | 393,944 | 393,248 | 393,663 |
| Accumulated deficit | -309,628 | -304,092 | -293,002 | -278,436 |
| Accumulated other comprehensive loss foreign currency translation adjustments | -18,559 | -15,731 | -15,868 | -12,937 |
| Total stockholders equity attributable to barinthus biotherapeutics plc shareholders | 66,399 | 74,208 | 84,465 | 102,377 |
| Noncontrolling interest | 79 | 84 | 96 | 104 |
| Total stockholders equity | 66,478 | 74,292 | 84,561 | 102,481 |
| Total liabilities and stockholders equity | 92,143 | 98,169 | 109,201 | 129,561 |
Barinthus Biotherapeutics plc. (BRNS)
Barinthus Biotherapeutics plc. (BRNS)